PTC Therapeutics, Inc. (PTCT): Capital Expenditures
$8.86M
Year ended 2025-12-31
-34.8%
3-year compound annual growth
-13.1%
5-year compound annual growth
+12.5%
10-year compound annual growth
| Period ended | Capital Expenditures | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $8.86M | +36.3% | 2026-02-19, From 2025-01-01 |
| 2024-12-31 | $6.50M | -77.1% | 2026-02-19, From 2024-01-01 |
| 2023-12-31 | $28.44M | -11.2% | 2026-02-19, From 2023-01-01 |
| 2022-12-31 | $32.02M | +13.5% | 2025-02-27, From 2022-01-01 |
| 2021-12-31 | $28.21M | +58.1% | 2024-02-29, From 2021-01-01 |
| 2020-12-31 | $17.84M | +29.7% | 2023-02-21, From 2020-01-01 |
| 2019-12-31 | $13.76M | +93.8% | 2022-02-22, From 2019-01-01 |
| 2018-12-31 | $7.10M | +128.9% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $3.10M | +74.6% | 2020-03-02, From 2017-01-01 |
| 2016-12-31 | $1.78M | -34.7% | 2019-03-01, From 2016-01-01 |
| 2015-12-31 | $2.72M | -41.7% | 2018-03-06, From 2015-01-01 |
| 2014-12-31 | $4.66M | +451.3% | 2017-03-16, From 2014-01-01 |
| 2013-12-31 | $846.0K | +347.6% | 2016-02-29, From 2013-01-01 |
| 2012-12-31 | $189.0K | +14.5% | 2015-03-02, From 2012-01-01 |
| 2011-12-31 | $165.1K | n/a | 2014-03-06, From 2011-01-01 |
Capital Expenditures at similar companies
| Company | Year ended | Capital Expenditures | Change YoY |
|---|---|---|---|
| PTC Therapeutics, Inc. (PTCT) | 2025-12-31 | $8.86M | +36.3% |
| Phibro Animal Health Corp (PAHC) | 2026-06-30 | $59.09M | +54.3% |
| Alkermes plc. (ALKS) | 2025-12-31 | $40.42M | +20.7% |
| Sarepta Therapeutics, Inc. (SRPT) | 2025-12-31 | $101.97M | -25.5% |
| Indivior Pharmaceuticals, Inc. (INDV) | 2025-12-31 | $66.00M | +127.6% |
| Prestige Consumer Healthcare Inc. (PBH) | 2026-03-31 | $11.18M | +35.9% |
| Acadia Pharmaceuticals Inc (ACAD) | 2025-12-31 | $4.69M | +796.7% |
| Amneal Pharmaceuticals, Inc. (AMRX) | 2025-12-31 | $70.06M | +34.9% |
| Madrigal Pharmaceuticals, Inc. (MDGL) | 2025-12-31 | $467.0K | -68.1% |
Compare PTCT, PAHC, ALKS, SRPT side by side · Screen every company in Pharmaceutical Preparations ↗